You have no items in your shopping cart.
Description
Research Area
Images & Validation
−
| Tested Applications | FC, ICC, IF |
|---|---|
| Dilution Range | Flow-Cyt=1ug/test, IF=1:100-500, ICC/IF=1:100-500 |
| Reactivity | Human, Mouse |
| Predicted Reactivity | Equine, Porcine, Rat |
Related Conjugates & Formulations
−Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Immunogen | KLH conjugated synthetic peptide derived from human SREBP-2 (951-1141/1141aa) |
| Target | SREBF2 |
| Purification | Affinity purified by Protein A |
| Conjugation | APC |
Storage & Handling
−| Storage | Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
|---|---|
| Buffer/Preservatives | 0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol. |
| Concentration | 1mg/ml |
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−SREBP2 Rabbit Polyclonal Antibody (APC-Cy7) [orb1604713]
FC, ICC, IF
Equine, Porcine, Rat
Human, Mouse
Rabbit
Polyclonal
APC/Cy7
100 μlSREBP2 Rabbit Polyclonal Antibody (APC-Cy5.5) [orb1604714]
FC, ICC, IF
Equine, Porcine, Rat
Human, Mouse
Rabbit
Polyclonal
APC/Cy5.5
100 μlSREBP2/SREBF2 Rabbit Polyclonal Antibody (APC) [orb2597736]
Human, Mouse, Rat
Rabbit
Polyclonal
APC
100 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
Protocol Information
Yoshihiro Sakano 1, Kei Sakano 1, Benjamin P Hurrell 1, Mohammad H Kazemi 1, Xin Li 1, Stephen Shen 1, Omid Akbari ICOS regulates IL-10 production in group 2 innate lymphoid cells via cholesterol and cortisol biosynthesis J Clin Invest, (2025)